» Articles » PMID: 24273721

Cerebral Magnetic Resonance Elastography in Supranuclear Palsy and Idiopathic Parkinson's Disease

Overview
Journal Neuroimage Clin
Publisher Elsevier
Specialties Neurology
Radiology
Date 2013 Nov 26
PMID 24273721
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Detection and discrimination of neurodegenerative Parkinson syndromes are challenging clinical tasks and the use of standard T1- and T2-weighted cerebral magnetic resonance (MR) imaging is limited to exclude symptomatic Parkinsonism. We used a quantitative structural MR-based technique, MR-elastography (MRE), to assess viscoelastic properties of the brain, providing insights into altered tissue architecture in neurodegenerative diseases on a macroscopic level. We measured single-slice multifrequency MRE (MMRE) and three-dimensional MRE (3DMRE) in two neurodegenerative disorders with overlapping clinical presentation but different neuropathology - progressive supranuclear palsy (PSP: N = 16) and idiopathic Parkinson's disease (PD: N = 18) as well as in controls (N = 18). In PSP, both MMRE (Δμ = - 28.8%, Δα = - 4.9%) and 3DMRE (Δ|G*|: - 10.6%, Δφ: - 34.6%) were significantly reduced compared to controls, with a pronounced reduction within the lentiform nucleus (Δμ = - 34.6%, Δα = - 8.1%; Δ|G*|: - 7.8%, Δφ: - 44.8%). MRE in PD showed a comparable pattern, but overall reduction in brain elasticity was less severe reaching significance only in the lentiform nucleus (Δμ n.s., Δα = - 7.4%; Δ|G*|: - 6.9%, Δφ: n.s.). Beyond that, patients showed a close negative correlation between MRE constants and clinical severity. Our data indicate that brain viscoelasticity in PSP and PD is differently affected by the underlying neurodegeneration; whereas in PSP all MRE constants are reduced and changes in brain softness (reduced μ and |G*|) predominate those of viscosity (α and φ) in PD.

Citing Articles

MRI-based whole-brain elastography and volumetric measurements to predict brain age.

Claros-Olivares C, Clements R, McIlvain G, Johnson C, Brockmeier A Biol Methods Protoc. 2025; 10(1):bpae086.

PMID: 39902188 PMC: 11790219. DOI: 10.1093/biomethods/bpae086.


Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders.

Ortega-Robles E, de Celis Alonso B, Cantillo-Negrete J, Carino-Escobar R, Arias-Carrion O Brain Sci. 2025; 15(1).

PMID: 39851446 PMC: 11763950. DOI: 10.3390/brainsci15010079.


The contributions of relative brain viscosity to brain function and health.

McIlvain G Brain Commun. 2024; 6(6):fcae424.

PMID: 39713240 PMC: 11660954. DOI: 10.1093/braincomms/fcae424.


The Networking Brain: How Extracellular Matrix, Cellular Networks, and Vasculature Shape the In Vivo Mechanical Properties of the Brain.

Bergs J, Morr A, Silva R, Infante-Duarte C, Sack I Adv Sci (Weinh). 2024; 11(31):e2402338.

PMID: 38874205 PMC: 11336943. DOI: 10.1002/advs.202402338.


Feasibility of assessing non-invasive intracranial compliance using FSI simulation-based and MR elastography-based brain stiffness.

Gholampour S Sci Rep. 2024; 14(1):6493.

PMID: 38499758 PMC: 10948846. DOI: 10.1038/s41598-024-57250-4.


References
1.
Freimann F, Muller S, Streitberger K, Guo J, Rot S, Ghori A . MR elastography in a murine stroke model reveals correlation of macroscopic viscoelastic properties of the brain with neuronal density. NMR Biomed. 2013; 26(11):1534-9. DOI: 10.1002/nbm.2987. View

2.
Golbe L, Ohman-Strickland P . A clinical rating scale for progressive supranuclear palsy. Brain. 2007; 130(Pt 6):1552-65. DOI: 10.1093/brain/awm032. View

3.
Posnansky O, Guo J, Hirsch S, Papazoglou S, Braun J, Sack I . Fractal network dimension and viscoelastic powerlaw behavior: I. A modeling approach based on a coarse-graining procedure combined with shear oscillatory rheometry. Phys Med Biol. 2012; 57(12):4023-40. DOI: 10.1088/0031-9155/57/12/4023. View

4.
Litvan I, Bhatia K, Burn D, Goetz C, Lang A, McKeith I . Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003; 18(5):467-86. DOI: 10.1002/mds.10459. View

5.
Fellner L, Jellinger K, Wenning G, Stefanova N . Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol. 2011; 121(6):675-93. PMC: 4730553. DOI: 10.1007/s00401-011-0833-z. View